Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Errors in the management of patients with Alzheimer's disease: analysis of problems and ways of their solution

Full Text:


Epidemiological data show that Alzheimer's disease (AD) is the most common cause of acquired cognitive impairment (CI). At the same time, according to statistics, vascular CI and vascular dementia predominate in Russia, which is mainly due to imperfect diagnosis, when any pathological condition associated with cerebral dysfunction in a patient with vascular risk factors is interpreted as dyscirculatory encephalopathy or chronic brain ischemia. However, this can be asthenoneurotic syndrome, migraine, vestibular dysfunction, and a number of neurodegenerative diseases, the most common condition of which is certainly AD. What is more, the treatment of age-related diseases, with the exception of acute vascular disease, is receiving manifestly inadequate attention. All this leads to the lack of a unified methodology for the management of these patients, to the impossibility to have adequate primary medical care, to the low detection rate of CI, to the prescription of drugs without appropriate indications, and to the denial of psychological correction methods. The review highlights the challenges facing the management of patients with AD and the possible ways of their solution.

About the Authors

A. Yu. Emelin
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044

I. V. Litvinenko
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044

V. Yu. Lobzin
S.M. Kirov Military Medical Academy, Ministry of Defense of Russia
Russian Federation
6, Academician Lebedev St., Saint Petersburg 194044


1. Доклад ВОЗ. Деменция: приоритет общественного здравоохранения. 2013;

2. Litvinenko IV, Emelin AYu, Lobzin VYu, Kolmakova KA. Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2019;11(3S):18-25. (In Russ.) doi: 10.14412/2074-2711-2019-3S-18-25

3. Lobzin VYu. Comprehensive early diagnosis of cognitive impairment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(11):72-9. (In Russ.)

4. Emelin AYu, Lobzin VYu. Complex differential diagnosis of cognitive disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(6-2):33-9. (In Russ.)

5. Petersen RC, Lopez O, Armstrong MJ, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018 Jan 16; 90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27.

6. Petersen R, Thomas R, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005 Jun 9;352(23):2379-88. Epub 2005 Apr 13.

7. Feldman H, Ferris S, Winblad B, et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol. 2007 Jun;6(6):501-12.

8. Abbott RD, White RD, Ross GW, et al. Walking and dementia in physically capable elderly men. JAMA. 2004 Sep 22;292(12):1447-53.

9. Scrameas N, Stern Y, Tang MX, et al. Mediterranean diet and risk for Alzheimer`s disease. Ann Neurol. 2006 Jun;59(6):877-9.

10. Kramer A, Bherer L, Colcombe S, et al. Environmental influences on cognitive and brain plasticity during aging. J Gerontol A Biol Sci Med Sci. 2004 Sep;59(9):M940-57.

11. Kivipelto M, Solomon A, Ahtiluoto S, et al. The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress. Alzheimers Dement. 2013 Nov;9(6):657-65. doi: 10.1016/j.jalz.2012.09.012. Epub 2013 Jan 17.

12. Hö rder H, Johansson L, Guo X, et al. Midlife cardiovascular fitness and dementia: A 44-year longitudinal population study in women. Neurology. 2018 Apr 10;90(15):e1298-e1305. doi: 10.1212/WNL.0000000000005290. Epub 2018 Mar 14.

13. Emelin AYu, Lobzin VYu, Vorob'ev SV, editors. Kognitivnye narusheniya: rukovodstvo dlya vrachei [Cognitive impairment: a guide for doctors]. Moscow; 2019. 416 p.

14. Antonenko LM, Parfenov VA. Cognitive and emotional disorders in middle age: diagnosis and treatment. Meditsinskii sovet. 2015;(10): 22-7. (In Russ.)

15. Chapman N, Huxley R, Anderson C, et al. Effects of a Perindopril-Based Blood PressureLowering Regimen on the Risk of Recurrent Stroke According to Stroke Subtype and Medical History. The PROGRESS Trial. Stroke. 2004 Jan;35(1):116-21. Epub 2003 Dec 11.

16. Etgen T, Sander D, Bickel H. Mild Cognitive Impairment and Dementia. The Importance of Modifiable Risk Factors. Dtsch Arztebl Int. 2011 Nov;108(44):743-50. doi: 10.3238/arztebl.2011.0743. Epub 2011 Nov 4.

17. Forette F, Seux ML, Staessen J, et al. Prevention of dementia in randomised doubleblind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 Oct 24; 352(9137):1347-51.

18. Loef M, Walach H. Fruit, vegetables and prevention of cognitive decline or dementia: a systematic review of cohort studies. J Nutr Health Aging. 2012 Jul;16(7):626-30.

19. Larouche E, Hudon C, Goulet S. Mindfulness mechanisms and psychological effects for aMCI patients: A comparison with psychoeducation. Complement Ther Clin Pract. 2019 Feb;34:93-104. doi: 10.1016/j.ctcp.2018.11.008. Epub 2018 Nov 12.

20. Woods B, O'Philbin L, Farrell EM, et al. Reminiscence therapy for dementia. Cochrane Database Syst Rev. 2018 Mar 1;3:CD001120. doi: 10.1002/14651858.CD001120.pub3.

21. O'Brien JT, Holmes C, Jones M, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol. 2017 Feb;31(2):147-168. doi: 10.1177/0269881116680924. Epub 2017 Jan 20.

22. Parfenov VA. Treatment of post-stroke cognitive impairment. The use Of Omaron. Russkii meditsinskii zhkrnal. Nevrologiya. 2010;18(16): 986-90. (In Russ.)

23. Order of the Ministry of health of the Russian Federation of 20.12.2012 №1228n гon approval of the standard of specialized medical care for Alzheimer's diseaseх.

24. Winblad B, Fioravanti M, Dolezal T, et al. Therapeutic use of nicergoline. Clin Drug Investig. 2008;28(9):533-52.

25. Smith E, Cieslak A, Barber P, et al. Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment. J Am Heart Assoc. 2017 May 5;6(5). pii: e005568. doi: 10.1161/JAHA.117.005568.

26. Fioravanti M, Flicker L. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment. Cochrane Database Syst Rev. 2001;(4):CD003159.

27. Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev. 2003;(1): CD003119.

28. Im JJ, Jeong HS, Park JS, et al. Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study. Dement Neurocogn Disord. 2017 Dec; 16(4):104-109. doi: 10.12779/dnd.2017.16.4.104. Epub 2017 Dec 31.

29. Golenkov AV, Malyshkina YuN, Spodina EA, Underov DA. Errors in the diagnosis and treatment of Alzheimer's disease. Vestnik Chuvashskogo universiteta. 2013;(3):397-401. (In Russ.)

30. Small G, Dubois B. A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch. Curr Med Res Opin. 2007 Nov;23(11):2705-13.

31. Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis. PLoS One. 2015 Apr 10;10(4):e0123289. doi: 10.1371/journal.pone.0123289. eCollection 2015.

32. Schmidt R, Hofer E, Bouwman J. EFNSENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur J Neurol. 2015 Jun;22(6):889-98. doi: 10.1111/ene.12707. Epub 2015 Mar 25.

33. Litvinenko IV, Naumov KM, Odinak MM. Correction of cognitive and non-cognitive symptoms of cerebrovascular disease. Zhurnal nevrologii i psikhiatrii im. C.C. Korsakova. 2014;114(4):35–40. (In Russ.)

For citation:

Emelin A.Y., Litvinenko I.V., Lobzin V.Y. Errors in the management of patients with Alzheimer's disease: analysis of problems and ways of their solution. Neurology, Neuropsychiatry, Psychosomatics. 2019;11(4):141-146. (In Russ.)

Views: 59

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)